Literature DB >> 22093006

Baby oil therapy for uremic pruritus in haemodialysis patients.

Tzu-Chen Lin1, Yu-Hung Lai, Su-Er Guo, Chin-Fang Liu, Jer-Chia Tsai, How-Ran Guo, Hsin-Tien Hsu.   

Abstract

AIMS: The purpose of this study was to investigate the effectiveness of chilled/un-chilled baby oil therapy for treating uremic pruritus in haemodialysis patients.
BACKGROUND: Uremic pruritus affects 50-90% of haemodialysis patients, which makes it one of the most common medical problems in this population. Pruritus can cause skin infection, desquamation, pathological skin change, sleep disorder, anxiety, depression and social dysfunction.
DESIGN: A prospective, pretest-post-test quasi-experimental design was used.
METHODS: Haemodialysis patients with uremic pruritus were recruited and randomly assigned to one of three groups: experimental group 1 (chilled baby oil treatment; n = 30), experimental group 2 (un-chilled baby oil treatment; n = 31) and a control group (routine care only; n = 32). Participants in experimental group 1 and experimental group 2 were treated with chilled and un-chilled baby oil, respectively, for 15 minutes at least once daily for three weeks. The control group received no intervention other than standard care. Data collection included demographic data and itch severity. Medical records were also reviewed.
RESULTS: The baseline characteristics of subjects in this study were as follows: 59% were male, mean age was 61·88 (SD 12·7) years, mean duration of haemodialysis was 5·31 years, mean duration of uremic pruritus was 40·58 (SD 37·8) months and mean intensity of uremic pruritus was mild. The anti-pruritic effects were significantly larger in subjects treated with either chilled or un-chilled baby oil than in those who received routine care. Anti-pruritic effects did not significantly differ between experimental group 1 and experimental group 2.
CONCLUSIONS: The study confirmed that, for relieving pruritus in haemodialysis patients, either chilled or un-chilled baby oil is as effective as moisturising lotions and cooling soothing agents. RELEVANCE TO CLINICAL PRACTICE: Applying baby oil is a simple, safe, inexpensive and easily administered treatment for itchy skin in haemodialysis patients. By preventing or reducing uremic pruritus, baby oil treatment may also improve quality of life in this patient group.
© 2011 Blackwell Publishing Ltd.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22093006     DOI: 10.1111/j.1365-2702.2011.03906.x

Source DB:  PubMed          Journal:  J Clin Nurs        ISSN: 0962-1067            Impact factor:   3.036


  6 in total

Review 1.  Pruritus in Kidney Disease.

Authors:  Sara A Combs; J Pedro Teixeira; Michael J Germain
Journal:  Semin Nephrol       Date:  2015-07       Impact factor: 5.299

Review 2.  Sleep Disorders, Restless Legs Syndrome, and Uremic Pruritus: Diagnosis and Treatment of Common Symptoms in Dialysis Patients.

Authors:  Jennifer S Scherer; Sara A Combs; Frank Brennan
Journal:  Am J Kidney Dis       Date:  2016-09-29       Impact factor: 8.860

3.  Interventions for itch in people with advanced chronic kidney disease.

Authors:  Daniel Hercz; Simon H Jiang; Angela C Webster
Journal:  Cochrane Database Syst Rev       Date:  2020-12-07

4.  Translation of the 5D Itching Scale from English to Malay, and Its Validation among Patients with Chronic Kidney Disease in Malaysia.

Authors:  Inayat Ur Rehman; David Bin-Chia Wu; Siew Mei Pauline Lai; Uma Devi Palanisamy; Soo Kun Lim; Tahir Mehmood Khan
Journal:  Front Med (Lausanne)       Date:  2017-11-08

5.  Safety of pregabalin among hemodialysis patients suffering from uremic pruritus.

Authors:  Tahir Mehmood Khan; Abdul Aziz Alhafez; Syed Azhar Syed Sulaiman; David Wu Bin Chia
Journal:  Saudi Pharm J       Date:  2015-01-24       Impact factor: 4.330

6.  Impact of Pruritus on Sleep Quality of Hemodialysis Patients: A Systematic Review and Meta-Analysis.

Authors:  Inayat Ur Rehman; Tahir Ali Chohan; Allah Bukhsh; Tahir Mehmood Khan
Journal:  Medicina (Kaunas)       Date:  2019-10-17       Impact factor: 2.430

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.